137 related articles for article (PubMed ID: 6713731)
1. The role of antibody and complement in the cellular response to Trypanosoma congolense.
Schmitz B; Gehrung M; Thornton M; Speth V
Clin Exp Immunol; 1984 Apr; 56(1):73-80. PubMed ID: 6713731
[TBL] [Abstract][Full Text] [Related]
2. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice.
Kaushik RS; Uzonna JE; Gordon JR; Tabel H
Exp Parasitol; 1999 Jun; 92(2):131-43. PubMed ID: 10366538
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of self-cure from Trypanosoma congolense infection in mice.
Pinder M; Chassin P; Fumoux F
J Immunol; 1986 Feb; 136(4):1427-34. PubMed ID: 3484768
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells.
Shi M; Wei G; Pan W; Tabel H
J Leukoc Biol; 2004 Aug; 76(2):399-405. PubMed ID: 15136584
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma congolense bloodstream forms evade complement lysis in vitro by shedding of immune complexes.
Frevert U; Reinwald E
Eur J Cell Biol; 1990 Aug; 52(2):264-9. PubMed ID: 2081529
[TBL] [Abstract][Full Text] [Related]
6. In vitro erythrophagocytosis by cultured macrophages stimulated with extraneous substances and those isolated from the blood, spleen and bone marrow of Boran and N'Dama cattle infected with Trypanosoma congolense and Trypanosoma vivax.
Taiwo VO; Anosa VO
Onderstepoort J Vet Res; 2000 Dec; 67(4):273-87. PubMed ID: 11206395
[TBL] [Abstract][Full Text] [Related]
7. Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection.
Haas KM; Taylor KA; MacHugh ND; Kreeger JM; Estes DM
J Leukoc Biol; 2001 Dec; 70(6):931-40. PubMed ID: 11739556
[TBL] [Abstract][Full Text] [Related]
8. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
9. Specific surface antigens expressed on activated mouse peritoneal macrophages and recognized by a novel monoclonal antibody.
Someya A
Immunology; 1985 Dec; 56(4):683-8. PubMed ID: 3908293
[TBL] [Abstract][Full Text] [Related]
10. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
11. CR3 (CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha and nitric oxide.
Pan W; Ogunremi O; Wei G; Shi M; Tabel H
Microbes Infect; 2006 Apr; 8(5):1209-18. PubMed ID: 16616573
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during trypanosoma congolense Tc13 Infections.
Magez S; Radwanska M; Drennan M; Fick L; Baral TN; Brombacher F; De Baetselier P
J Infect Dis; 2006 Jun; 193(11):1575-83. PubMed ID: 16652287
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement.
Peppoloni S; Mancianti S; Volpini G; Nuti S; Ruggiero P; Rappuoli R; Blasi E; Del Giudice G
Eur J Immunol; 2002 Oct; 32(10):2721-5. PubMed ID: 12355423
[TBL] [Abstract][Full Text] [Related]
14. Identification of an antigen specific to Trypanosoma congolense by using monoclonal antibodies.
Parish NM; Morrison WI; Pearson TW
J Immunol; 1985 Jan; 134(1):593-7. PubMed ID: 3880577
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
Wolff EA; Schreiber GJ; Cosand WL; Raff HV
Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma theileri: antibody-dependent killing by purified populations of bovine leucocytes.
Townsend J; Duffus WP
Clin Exp Immunol; 1982 May; 48(2):289-99. PubMed ID: 7105486
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the complement system to antibody-mediated binding of Trypanosoma gambiense to macrophages.
Takayanagi T; Kawaguchi H; Yabu Y; Itoh M; Appawu MA
J Parasitol; 1987 Apr; 73(2):333-41. PubMed ID: 3585629
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis of antibody-sensitized Trypanosoma brucei in vitro by bovine peripheral blood monocytes.
Ngaira JM; Nantulya VM; Musoke AJ; Hirumi K
Immunology; 1983 Jun; 49(2):393-400. PubMed ID: 6852873
[TBL] [Abstract][Full Text] [Related]
19. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated killing of myeloma tumour cells: differences in susceptibility to lysis by antibodies and complement are independent of antigen expression and antibody binding.
Celis B; Celis E
Immunology; 1983 Jun; 49(2):321-8. PubMed ID: 6343234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
